Q1 2026 earnings call highlights: revenue, margins, guidance, cash outlook, Tempus AI deal, and Alzheimer’s diagnostics plans—read now.
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "IVD Reagents Market by Type (Antibodies, Nucleic Acid Probes), Technology (Hematology), Application (Genetic Testing, Autoimmune Disease), Test Type ...
On January 5, the US Food and Drug Administration (FDA) issued a new draft Guidance on Investigational IVDs Used in Clinical Investigations of Therapeutic Products. Based on concerns that drug ...
The Saudi Arabia in vitro diagnostics (IVD) market is set for steady growth, driven by the increasing prevalence of chronic ...
DUBLIN--(BUSINESS WIRE)--The "IVD Market Trends Report - 2023" report has been added to ResearchAndMarkets.com's offering. The analyst continues to be diligent in outlining the IVD market and it's ...
IVD is a key enzyme in leucine catabolism, catalyzing the conversion of isovaleryl-CoA to 3-methylcrotonyl-CoA. Defects in IVD function lead to toxic accumulation of metabolites such as isovaleric ...
According to GlobalData analyst Dr Andrew S Thompson, the deal signals Thermo Fisher’s move away from the IVD space.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results